论文部分内容阅读
高脂血症与冠心病和其他动脉粥样硬化的患病率和病死率密切相关,预防冠心病的重点在于调节血脂、防治动脉粥样硬化。本文对432例冠心病患者接受调脂治疗的情况进行客观分析,以期为临床提供一定参考。1 对象与方法1.1 对象。随机选定1999年度明确诊断为冠心病,必须接受冠心病二级预防又未接受抗凝与再灌注治疗的患者432 例;年龄40-80岁,男。156例,女276例;合并高血压144例, 脑梗死144例,高脂血症357冽,糖尿病69例,还有心绞痛、心肌梗死及高脂血症患者。
Hyperlipidemia and coronary heart disease and other atherosclerosis prevalence and mortality are closely related to the prevention of coronary heart disease focus on regulating blood lipids, prevention and treatment of atherosclerosis. In this paper 432 cases of coronary heart disease in patients receiving lipid-lowering treatment of the objective analysis of the situation, with a view to provide some clinical reference. 1 objects and methods 1.1 object. Randomly selected in 1999 a clear diagnosis of coronary heart disease, coronary heart disease must be secondary prevention and did not receive anticoagulant and reperfusion treatment of 432 patients; aged 40-80 years old, male. 156 cases and 276 cases of women; 144 cases of hypertension, 144 cases of cerebral infarction, 357% of hyperlipidemia, 69 cases of diabetes mellitus, angina pectoris, myocardial infarction and hyperlipidemia.